Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Cash from Operations (2016 - 2025)

Historic Cash from Operations for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to -$6.2 million.

  • GeoVax Labs' Cash from Operations rose 3318.28% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.3 million, marking a year-over-year increase of 1078.74%. This contributed to the annual value of -$24.7 million for FY2024, which is 197.88% up from last year.
  • Latest data reveals that GeoVax Labs reported Cash from Operations of -$6.2 million as of Q3 2025, which was up 3318.28% from -$4.3 million recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Cash from Operations ranged from a high of -$1.3 million in Q2 2021 and a low of -$10.3 million during Q4 2023
  • Moreover, its 5-year median value for Cash from Operations was -$5.1 million (2023), whereas its average is -$5.1 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 47702.4% in 2021, then skyrocketed by 6784.82% in 2024.
  • GeoVax Labs' Cash from Operations (Quarter) stood at -$6.7 million in 2021, then fell by 5.7% to -$7.1 million in 2022, then tumbled by 45.49% to -$10.3 million in 2023, then increased by 24.56% to -$7.8 million in 2024, then rose by 19.88% to -$6.2 million in 2025.
  • Its Cash from Operations stands at -$6.2 million for Q3 2025, versus -$4.3 million for Q2 2025 and -$6.0 million for Q1 2025.